Talukdar Lavina

Talukdar Lavina is listed in filings as Director at Monopar Therapeutics Inc.. This profile follows SEC Form 4 activity through Dec 8, 2025, including 2 public disclosures. Recent filings connect the profile to Monopar Therapeutics Inc. (MNPR). The current snapshot covers public activity from Mar 7, 2025 to Dec 8, 2025. Reported amounts are shown as $222.0K to $180.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.